From Medscape Ophthalmology

Coverage from the

American Society of Retina Specialists (ASRS) 2023 Annual Meeting

July 28 - August 01, 2023; Seattle, Washington

July 28 - August 01, 2023 Seattle, Washington

Conference News

ASRS 2023 Long-Term Outcomes of Pegcetacoplan for GA Show Promise
Medscape Medical News, August 8, 2023
ASRS 2023 Complications From Geographic Atrophy Drug Fuel Questions
Medscape Medical News, August 7, 2023
ASRS 2023 Do GLP-1 Agonists Worsen Diabetic Retinopathy?
Medscape Medical News, August 3, 2023
Biosimilars Comparable to Aflibercept in Macular Disease
Medscape Medical News, August 3, 2023

Higher Aflibercept Dose Safe as 2 mg
Medscape Medical News, August 2, 2023
ASRS 2023 Study Shows Vision, Anatomy Stable With Port System for AMD
Medscape Medical News, August 2, 2023
ASRS 2023 Study: AMD Gene Therapy Demonstrates Vision Stabilization
Medscape Medical News, August 1, 2023
ASRS 2023 From Chronic Care to Zebras: Clinical Pearls in Uveitis
Medscape Medical News, July 31, 2023

Popular News From ASRS 2022

Methotrexate Could Reduce the Risk for Retinal Redetachment Intravitreal injections with methotrexate appear to reduce scar formation after retinal reattachment even in patients with proliferative diabetic retinopathy.
Medscape Medical News, Jul 20, 2022
Metformin Shows Potential to Prevent Macular Degeneration People prescribed the diabetes drug metformin may be less likely to develop age-related macular degeneration.
Medscape Medical News, Jul 18, 2022
Light Treatment Shows Promise in Dry Macular Degeneration Photobiomodulation may be the most promising treatment yet for dry age-related macular degeneration.
Medscape Medical News, Jul 21, 2022

Medscape Ophthalmology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Highlights From ASRS 2023
Timothy G. Murray, MD, MBA

Previous Coverage

Related Resource